Nanjing Vazyme Biotech Co.,Ltd 688105.SS Stock
Nanjing Vazyme Biotech Co.,Ltd Price Chart
Nanjing Vazyme Biotech Co.,Ltd 688105.SS Financial and Trading Overview
| Nanjing Vazyme Biotech Co.,Ltd stock price | 25.01 CNY |
| Previous Close | 32.35 CNY |
| Open | 32.3 CNY |
| Bid | 32.16 CNY x N/A |
| Ask | 32.17 CNY x N/A |
| Day's Range | 32 - 32.6 CNY |
| 52 Week Range | 31.13 - 90 CNY |
| Volume | 1.13M CNY |
| Avg. Volume | 2.44M CNY |
| Market Cap | 12.87B CNY |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 114.89285 |
| EPS (TTM) | -0.57 CNY |
| Forward Dividend & Yield | 1.25 (3.86%) |
| Ex-Dividend Date | June 7, 2023 |
| 1y Target Est | 61.09 CNY |
688105.SS Valuation Measures
| Enterprise Value | 10.33B CNY |
| Trailing P/E | 114.89285 |
| Forward P/E | 23.143885 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.4437256 |
| Price/Book (mrq) | 2.828878 |
| Enterprise Value/Revenue | 3.568 |
| Enterprise Value/EBITDA | 27.769 |
Trading Information
Nanjing Vazyme Biotech Co.,Ltd Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -62.81% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 90 CNY |
| 52 Week Low | 31.13 CNY |
| 50-Day Moving Average | 36.47 CNY |
| 200-Day Moving Average | 54.36 CNY |
688105.SS Share Statistics
| Avg. Volume (3 month) | 2.44M CNY |
| Avg. Daily Volume (10-Days) | 2.9M CNY |
| Shares Outstanding | 400.01M |
| Float | 102.55M |
| Short Ratio | N/A |
| % Held by Insiders | 70.80% |
| % Held by Institutions | 11.34% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 1.25 |
| Trailing Annual Dividend Yield | 3.86% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 1.0714 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 3.87% |
| Operating Margin (ttm) | 10.62% |
| Gross Margin | 57.13% |
| EBITDA Margin | 12.84% |
Management Effectiveness
| Return on Assets (ttm) | 3.26% |
| Return on Equity (ttm) | 2.43% |
Income Statement
| Revenue (ttm) | 2.9B CNY |
| Revenue Per Share (ttm) | 7.31 CNY |
| Quarterly Revenue Growth (yoy) | -69.00000000000000000000000000000000% |
| Gross Profit (ttm) | 2.18B CNY |
| EBITDA | 372.06M CNY |
| Net Income Avi to Common (ttm) | 112.26M CNY |
| Diluted EPS (ttm) | 0.28 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.8B CNY |
| Total Cash Per Share (mrq) | 9.5 CNY |
| Total Debt (mrq) | 1.19B CNY |
| Total Debt/Equity (mrq) | 26.13 CNY |
| Current Ratio (mrq) | 3.126 |
| Book Value Per Share (mrq) | 11.372 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 553.36M CNY |
| Levered Free Cash Flow (ttm) | -271137056 CNY |
Profile of Nanjing Vazyme Biotech Co.,Ltd
| Country | China |
| State | N/A |
| City | Nanjing |
| Address | Building D2 |
| ZIP | 210033 |
| Phone | 86 25 8577 1179 |
| Website | https://www.vazyme.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 4096 |
Nanjing Vazyme Biotech Co., Ltd. offers technology solutions for life science, biomedicine, and in vitro diagnostics. The company offers reagents for molecular biology research, such as nucleic acid extraction, PCR, cloning/mutagenesis, nucleic acid electrophoresis, reverse transcription, real-time PCR (qPCR), genome editing, and cell biology/protein research; reagents for NGS library preparation, including automated liquid handling workstation, DNA sequencing, RNA sequencing, single cell-seq series, epigenetics series, beads series, quantification series, and capture series; reagents for molecular diagnosis comprising isothermal amplification reagents, PCR, reverse transcription, real-time PCR, one-step series, and animal detection; and reagents for bio-medicine, such as vaccine effectiveness evaluations and vaccine manufacture. Nanjing Vazyme Biotech Co., Ltd. was founded in 2012 and is based in Nanjing, China.
Q&A For Nanjing Vazyme Biotech Co.,Ltd Stock
What is a current 688105.SS stock price?
Nanjing Vazyme Biotech Co.,Ltd 688105.SS stock price today per share is 25.01 CNY.
How to purchase Nanjing Vazyme Biotech Co.,Ltd stock?
You can buy 688105.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Nanjing Vazyme Biotech Co.,Ltd?
The stock symbol or ticker of Nanjing Vazyme Biotech Co.,Ltd is 688105.SS.
Which industry does the Nanjing Vazyme Biotech Co.,Ltd company belong to?
The Nanjing Vazyme Biotech Co.,Ltd industry is Biotechnology.
How many shares does Nanjing Vazyme Biotech Co.,Ltd have in circulation?
The max supply of Nanjing Vazyme Biotech Co.,Ltd shares is 400.01M.
What is Nanjing Vazyme Biotech Co.,Ltd Price to Earnings Ratio (PE Ratio)?
Nanjing Vazyme Biotech Co.,Ltd PE Ratio is now.
What was Nanjing Vazyme Biotech Co.,Ltd earnings per share over the trailing 12 months (TTM)?
Nanjing Vazyme Biotech Co.,Ltd EPS is -0.57 CNY over the trailing 12 months.
Which sector does the Nanjing Vazyme Biotech Co.,Ltd company belong to?
The Nanjing Vazyme Biotech Co.,Ltd sector is Healthcare.
Stocks Related By Marketcap
- Shenzhen Special Economic Zone Real Estate & Properties (Group) Co., Ltd. 200029.SZ Stock
- Jinyu Bio-technology Co., Ltd. 600201.SS Stock
- China Nonferrous Metal Industry's Foreign Engineering and Construction Co.,Ltd. 000758.SZ Stock
- Toly Bread Co.,Ltd. 603866.SS Stock
- YOUNGY Co., Ltd. 002192.SZ Stock